(Q40380108)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Christoph Ebenbichler

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

J Engl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

M Laimer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

A Niederwanger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

M Kranebitter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

M Starzinger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

M T Pedrini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

W W Fleischhacker

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

J R Patsch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

English

0 references

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

1089-1096

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16130009%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001729

6 January 2020

exact match

0 references

cites work

Association of olanzapine-induced weight gain with an increase in body fat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Consensus development conference on antipsychotic drugs and obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Different effects of antipsychotic drugs on insulin release in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Olanzapine-induced hyperglycemia: role of humoral insulin resistance-inducing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

The phosphoinositide 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

PI3K: downstream AKTion blocks apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Human muscle glycogen synthase cDNA sequence: a negatively charged protein with an asymmetric charge distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

New onset diabetes and atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Atypical antipsychotics and hyperglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Free fatty acids and pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Insulin signalling and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Pharmacokinetics and tissue distribution of olanzapine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Insulin release from human pancreatic islets in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Effect of tumor necrosis factor-alpha on insulin-stimulated mitogen-activated protein kinase cascade in cultured rat skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Effect of tumor necrosis factor-alpha on insulin action in cultured rat skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

Mechanism of activation of protein kinase B by insulin and IGF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

7 January 2021

GSK3: a SHAGGY frog story

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

7 January 2021

Phosphorylation of sites 3a and 3b (Ser640 and Ser644) in the control of rabbit muscle glycogen synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

7 January 2021

Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

7 January 2021

Effects of drugs on glucose and tolbutamide-stimulated insulin release from isolated rat islets of Langerhans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

7 January 2021

Effect of chlorpromazine on insulin release in mice: comparison between in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001729

7 January 2021